Three key lessons for digital health investors from the demise of Babylon Health
When Babylon Health listed in New York in 2021, the telehealth company was valued at $4.2bn. Within a year later the stock price collapsed and it later filed for bankruptcy. The company’s British assets sold for only £500k. We look at three key lessons for digital health investors.
Operators of acute hospitals, day-surgery and outpatient facilities including opthalmic, imaging centres, cancer and radiotherapy clinics, and ambulance services
Market opportunities for surgical ophthalmic equipment and products
Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products
Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products
Radiopharmaceuticals - where hot molecules meet cold capital
Radiopharmaceuticals remains a hot topic in 2026, with continued investment from both big and mid-sized pharma, and private equity in the last twelve months. Will Johnson, engagement manager, Lakshiv Dhingra, clinical fellow, and Victor Chua, Partner, at Mansfield Advisors outline key developments and potential asset classes for private equity investors considering the sector.
Johan Ottosson, Senior Associate and Dr. Victor Chua, Senior Partner see significant opportunities in the market for surgical ophthalmic equipment and products
We are highly competitive in our offering, and reward hard work and commitment. We offer a great benefits package, fantastic team building events, and opportunities for secondments with clients.
